Source: Healio Coverage
January 01, 2022
1 min read
Save

Tunable IOLs, FDA news lead December cataract surgery coverage

Source: Healio Coverage
You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

December’s top cataract surgery stories include a blog entry speculating about the impact of tunable IOLs on exchanges and an FDA approvable letter for the IC-8 IOL.

Read December’s best-performing cataract surgery stories below.

BLOG: Tunable IOLs will end exchanges

Through their careers, most cataract surgeons become extremely comfortable with and adept at performing phacoemulsification, removing even the most challenging lenses and placing lens implants with little stress. Read more.

AcuFocus receives approvable letter from FDA for IC-8 IOL

AcuFocus has received an approvable letter from the FDA regarding the IC-8 small aperture IOL, according to a press release from the company. Read more.

Tecnis Synergy shows good performance at all distances in refractive lens exchange
Read more.

Novel intraocular ring enhances IOL stability, prevents PCO

A novel intraocular ring provides good centration and stable holding of IOLs in the capsular bag, while effectively preventing posterior capsule opacification. Read more.

Using intracanalicular dexamethasone insert after cataract surgery saves office time

NEW ORLEANS — Using Dextenza as a postoperative steroid treatment after cataract surgery saved practices about 40 staff hours per week on patient education and callbacks, according to a survey. Read more.